Home MSJ

MSJ

In operation
Series A+
Recombinant Gene Editing Technology Researcher

Basic Information

MSJ Biotech Co., Ltd. has achieved remarkable results in the field of gene editing with its forward-looking R&D concepts and leading technical strength. The company's unique recombinant gene editing technology ingeniously combines recombinant collagen protein with recombinant fibronectin, forming a distinctive microcapsule model. This technology not only ensures the bioactivity of collagen but also enhances its permeability and stability in the skin. MSJ has developed this technology into a comprehensive technical platform, which has the potential to develop proteins needed for various parts of the human body.
--
Jiangsu,China
15~50 people
July 19, 2021
--
kenzhaogutai@163.com